A study in Canada looked at the effect of recreational cannabis legalization on alcohol sales across all provinces.
Researchers in Canada examined sales of alcohol compared with sales of recreational cannabis to gauge the effect of legalization in Canada in 2018 (1). The researchers noted that the data on cannabis being used in conjunction with alcohol or instead of alcohol is currently inconclusive (1). Previous US studies on this subject are not necessarily applicable to Canada for a variety of reasons, they also explained (1). Their study, “Association Between Non-Medical Cannabis Legalization and Alcohol Sales: Quasi-Experimental Evidence from Canada,” was published in Drug and Alcohol Dependence in February 2024 and is reportedly the first of its kind (1).
Using an Interrupted Time Series design, researchers examined monthly data on sale of spirits and of bottled, canned, and kegged beer sales before and after 2018 (1). Specifically, data on spirits sales from January 2016 to February 2020 along with beer sales from January 2012 to February 2020 was analyzed for each province (1). Cannabis use in the country increased from about 15% before legalization to nearly 17% in 2019 (1). Overall, they found that the legalization of cannabis was associated with a decline in some alcohol sales (1).
As listed in the study, highlights from the research include the following (1):
The results suggested that cannabis may be being used as a substitute for beer, researchers proposed (1). In the study’s discussion, researchers argued that though the decline in beer sales was modest, it was economically significant (1). Furthermore, the results could have implications for public health policies, particularly with preventing cannabis sales to minors (1). To overcome the limitations of this study, further studies could include long-term, post-pandemic data, more varied demographic groups, and the inclusion of other types of alcohol (1).
Related: see the effects of “Dry January” on cannabis sales compared to alcohol sales in the US.
Reference
Ep 24, Part II: Data Transparency in Cannabis Testing with Yasha Khan
December 12th 2024Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.
Ep 24, Part I: Data Transparency in Cannabis Testing with Yasha Khan
November 21st 2024Evan Friedmann interviews Yasha Khan, co-founder of MCR Labs, about his journey into the cannabis industry and his efforts to promote transparency and integrity in laboratory practices. Yasha discusses the origins of MCR Labs, which began in Massachusetts to meet the needs of the soon-to-be legal medical cannabis market. He explains the challenges faced, including result manipulation by labs and the impact on public health. Yasha's Freedom of Information Act (FOIA) project aimed to gather testing data from 37 states, revealed significant discrepancies in potency and mold results. Despite some states' reluctance to share data, Yasha has made much of this data public, leading to collaborative research and publications on various aspects of cannabis testing.